ALZCHEM GROUP AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.8 EUR | +2.00% |
|
-1.93% | +76.15% |
| 03-15 | German arms industry receives EU millions for projects | DP |
| 03-01 | Transcript : AlzChem Group AG, 2023 Earnings Call, Mar 01, 2024 |
| Sales 2024 * | 564M 603M 48.32B | Sales 2025 * | 589M 630M 50.44B | Capitalization | 466M 498M 39.91B |
|---|---|---|---|---|---|
| Net income 2024 * | 40M 42.77M 3.42B | Net income 2025 * | 45M 48.11M 3.85B | EV / Sales 2024 * | 0.89 x |
| Net Debt 2024 * | 36.55M 39.08M 3.13B | Net Debt 2025 * | 32.8M 35.07M 2.81B | EV / Sales 2025 * | 0.85 x |
| P/E ratio 2024 * |
11.4
x | P/E ratio 2025 * |
10.3
x | Employees | 1,607 |
| Yield 2024 * |
2.89% | Yield 2025 * |
3.21% | Free-Float | 99% |
More Fundamentals
* Assessed data
More news
Latest transcript on AlzChem Group AG
More press releases
More news
| 1 day | +2.00% | ||
| 1 week | -1.93% | ||
| Current month | +24.12% | ||
| 1 month | +29.75% | ||
| 3 months | +81.75% | ||
| 6 months | +117.06% | ||
| Current year | +76.15% |
1 week
40.10
48.00
1 month
36.6048.00
Current year
22.2048.00
1 year
17.5548.00
3 years
14.8048.00
5 years
11.0048.00
10 years
11.0050.82
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 01/10/17 | |
Andreas Losler
DFI | Director of Finance/CFO | - | 31/12/11 |
| Chief Operating Officer | 63 | 01/10/17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Markus Zöllner
CHM | Chairman | 56 | 03/08/17 |
Steve Röper
BRD | Director/Board Member | 48 | 01/10/17 |
| Director/Board Member | 51 | 03/08/17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 45.8 | +2.00% | 28,932 |
| 25/04/24 | 44.9 | -5.07% | 65,924 |
| 24/04/24 | 47.3 | +1.28% | 18,414 |
| 23/04/24 | 46.7 | +0.21% | 10,425 |
| 22/04/24 | 46.6 | -0.21% | 12,864 |
Delayed Quote Xetra, April 26, 2024 at 04:36 pm
More quotes
Alzchem Group AG, fka AlzChem Group AG, is a Germany-based group parent company for a vertically integrated producer of chemical products based on the calcium carbide/calcium cyanamide chain. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The Company produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. It also provides related services. The Company operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.
Sector
Diversified Chemicals
Calendar
30/04/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
45.8
EUR
Average target price
43.1
EUR
Spread / Average Target
-5.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +76.15% | 498M | |
| -0.19% | 74.89B | |
| +0.09% | 46.52B | |
| -4.19% | 30.82B | |
| +9.85% | 18.19B | |
| -10.05% | 11.54B | |
| -8.09% | 9.73B | |
| +2.79% | 9.4B | |
| +6.35% | 9.37B | |
| +3.85% | 8.11B |
- Stock Market
- Equities
- ACT Stock
